Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/can-gender-specific-screening-tools-aid-recognition-male-depression-3 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/if-first-you-don%E2%80%99t-succeed-try-another-cgrp-antibody-migraine-prevention-1 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/should-antipsychotic-medications-be-stopped-early-possible-after-first-episode-1 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter clicked Clicked https://progress.im/en/newsletter/confirm/remove Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/personalizing-antipsychotic-therapy-improve-functional-outcomes-and-quality-life-4 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://progress.im/en/newsletter/confirm/remove Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/can-gender-specific-screening-tools-aid-recognition-male-depression-3 Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/if-first-you-don%E2%80%99t-succeed-try-another-cgrp-antibody-migraine-prevention-1 Анонимен
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/can-gender-specific-screening-tools-aid-recognition-male-depression-3 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/if-first-you-don%E2%80%99t-succeed-try-another-cgrp-antibody-migraine-prevention-1 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/should-antipsychotic-medications-be-stopped-early-possible-after-first-episode-1 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter clicked Clicked https://progress.im/en/newsletter/confirm/remove Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/personalizing-antipsychotic-therapy-improve-functional-outcomes-and-quality-life-4 Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter opened Opened Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://progress.im/en/newsletter/confirm/remove Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/can-gender-specific-screening-tools-aid-recognition-male-depression-3 Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en Анонимен
Newsletter opened Opened Анонимен
Newsletter clicked Clicked https://belgium-luxembourg.progress.im/en/content/if-first-you-don%E2%80%99t-succeed-try-another-cgrp-antibody-migraine-prevention-1 Анонимен